126 related articles for article (PubMed ID: 12389614)
1. Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) family.
Schneider C; Hübinger G
Leuk Lymphoma; 2002 Jul; 43(7):1355-66. PubMed ID: 12389614
[TBL] [Abstract][Full Text] [Related]
2. Signal transduction in anaplastic large cell lymphoma cells (ALCL) mediated by the tumor necrosis factor receptor CD30.
Schneider C; Stöhr D; Merz H; Hübinger G
Leuk Lymphoma; 2004 May; 45(5):1009-15. PubMed ID: 15291361
[TBL] [Abstract][Full Text] [Related]
3. CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival.
Duckett CS; Thompson CB
Genes Dev; 1997 Nov; 11(21):2810-21. PubMed ID: 9353251
[TBL] [Abstract][Full Text] [Related]
4. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines.
Gruss HJ; Boiani N; Williams DE; Armitage RJ; Smith CA; Goodwin RG
Blood; 1994 Apr; 83(8):2045-56. PubMed ID: 8161776
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells.
Mir SS; Richter BW; Duckett CS
Blood; 2000 Dec; 96(13):4307-12. PubMed ID: 11110706
[TBL] [Abstract][Full Text] [Related]
6. A novel domain in the CD30 cytoplasmic tail mediates NFkappaB activation.
Horie R; Aizawa S; Nagai M; Ito K; Higashihara M; Ishida T; Inoue J; Watanabe T
Int Immunol; 1998 Feb; 10(2):203-10. PubMed ID: 9533448
[TBL] [Abstract][Full Text] [Related]
7. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
Gruss H-J ; Herrmann F
Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
[TBL] [Abstract][Full Text] [Related]
8. mRNA expression patterns indicate CD30 mediated activation of different apoptosis pathways in anaplastic large cell lymphoma but not in Hodgkin's lymphoma.
Staber PB; Noehammer C; Dürkop H; Schauer S; Kenner L; Linkesch W; Hoefler G
Leuk Res; 2006 Mar; 30(3):343-8. PubMed ID: 16198418
[TBL] [Abstract][Full Text] [Related]
9. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors.
Lee SY; Park CG; Choi Y
J Exp Med; 1996 Feb; 183(2):669-74. PubMed ID: 8627180
[TBL] [Abstract][Full Text] [Related]
10. CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells.
Hirsch B; Hummel M; Bentink S; Fouladi F; Spang R; Zollinger R; Stein H; Dürkop H
Am J Pathol; 2008 Feb; 172(2):510-20. PubMed ID: 18187570
[TBL] [Abstract][Full Text] [Related]
11. Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation.
Dürkop H; Hirsch B; Hahn C; Foss HD; Stein H
J Pathol; 2003 Jun; 200(2):229-39. PubMed ID: 12754742
[TBL] [Abstract][Full Text] [Related]
12. Expression and a role of CD30 in regulation of T-cell activity.
Tarkowski M
Curr Opin Hematol; 2003 Jul; 10(4):267-71. PubMed ID: 12799531
[TBL] [Abstract][Full Text] [Related]
13. CD30: expression and function in health and disease.
Horie R; Watanabe T
Semin Immunol; 1998 Dec; 10(6):457-70. PubMed ID: 9826579
[TBL] [Abstract][Full Text] [Related]
14. CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity.
Lee SY; Lee SY; Kandala G; Liou ML; Liou HC; Choi Y
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9699-703. PubMed ID: 8790394
[TBL] [Abstract][Full Text] [Related]
15. The role of CD30 in the pathogenesis of haematopoietic malignancies.
Al-Shamkhani A
Curr Opin Pharmacol; 2004 Aug; 4(4):355-9. PubMed ID: 15251128
[TBL] [Abstract][Full Text] [Related]
16. Extremely rapid and intense induction of apoptosis in human eosinophils by anti-CD30 antibody treatment in vitro.
Matsumoto K; Terakawa M; Miura K; Fukuda S; Nakajima T; Saito H
J Immunol; 2004 Feb; 172(4):2186-93. PubMed ID: 14764685
[TBL] [Abstract][Full Text] [Related]
17. CD30-induced up-regulation of the inhibitor of apoptosis genes cIAP1 and cIAP2 in anaplastic large cell lymphoma cells.
Hübinger G; Schneider C; Stöhr D; Ruff H; Kirchner D; Schwänen C; Schmid M; Bergmann L; Müller E
Exp Hematol; 2004 Apr; 32(4):382-9. PubMed ID: 15050749
[TBL] [Abstract][Full Text] [Related]
18. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins.
Gedrich RW; Gilfillan MC; Duckett CS; Van Dongen JL; Thompson CB
J Biol Chem; 1996 May; 271(22):12852-8. PubMed ID: 8662842
[TBL] [Abstract][Full Text] [Related]
19. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
20. CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell line.
Wendtner CM; Schmitt B; Gruss HJ; Druker BJ; Emmerich B; Goodwin RG; Hallek M
Cancer Res; 1995 Sep; 55(18):4157-61. PubMed ID: 7545087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
